Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study-Reference-Cited by-同舟云学术

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

Published:2010-03 Issue:3 Volume:11 Page:275-280
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Thomas David,Henshaw Robert,Skubitz Keith,Chawla Sant,Staddon Arthur,Blay Jean-Yves,Roudier Martine,Smith Judy,Ye Zhishen,Sohn Winnie,Dansey Roger,Jun Susie

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. Giant cell tumour of bone;Mendenhall;Am J Clin Oncol,2006

2. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts;Zheng;Histol Histopathol,2001

3. Giant-cell tumour of bone;Szendroi;J Bone Joint Surg Br,2004

4. Surgical treatment and prognostic factors in giant-cell tumour of bone;Szendroi;Acta Chir Orthop Traumatol Cech,2003

5. Malignancy in giant cell tumour;Bullough,2002

Cited by 584 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center;Journal of Orthopaedic Surgery and Research;2024-08-17

2. The Role of Denosumab Treatment in Recurrent Giant Cell Bone Tumor of the Orbit;Ophthalmic Plastic & Reconstructive Surgery;2024-07-10

3. Aneurysmal bone cysts therapy using monoclonal human antibodies to RANKL;N.N. Priorov Journal of Traumatology and Orthopedics;2024-07-04

4. A Short Course of Preoperative Denosumab Injection Followed by Surgery in High-Risk Giant Cell Tumors of the Extremities: A Retrospective Study;Indian Journal of Surgical Oncology;2024-06-26

5. Efficacy and safety of denosumab de‑escalation in giant cell tumor of bone;Oncology Letters;2024-06-21